Richard Allan Ehrenkranz, MD

Richard Allan Ehrenkranz, MD
Neonatology
Accepting new patients? Yes
Referrals required? From physicians only
Patient type treated: Child

Richard A. Ehrenkranz, MD, is a neonatologist and director of clinical research for the neonatal intensive care unit (NICU) at Yale New Haven Children’s Hospital, where he has worked since 1978. He is also a director of the NICU GRAD Program, a follow-up program for premature infants and babies who need surgery or who were born with serious medical conditions and were cared for in the NICU. He specializes in nutritional requirements of premature and low-birthweight babies. “My current focus is on early nutritional support for extremely preterm infants to improve growth and developmental outcomes,” he says.

Dr. Ehrenkranz is a professor of pediatrics (neonatal-perinatal medicine) and of obstetrics, gynecology and reproductive sciences at Yale School of Medicine. In addition to his research on neonatal nutrition, he has been Yale’s principal investigator for numerous multicenter clinical investigations and randomized trials, including a treatment that reduces the incidence of neurological damage in babies deprived of oxygen during birth by cooling them.

Connecticut Magazine has listed Dr. Ehrenkranz as one of the Top Doctors in the state in his field. He has been listed by Castle Connolly Medical Ltd as one of America’s Top Doctors and has also been listed in Who’s Who in America.

  • Professor of Pediatrics (Neonatology) and of Obstetrics, Gynecology, and Reproductive Sciences
  • Provider, Yale NICU GRAD Program

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.